Jubilant Pharmova Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Jubilant Pharmova Limited generated cash of $9,713,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,325,000,000 last year. Net change in cash is therefore -$575,000,000.
Cash Flow
| 2010 | 7.09B | -2.79B | -2.98B |
|---|---|---|---|
| 2011 | 3.88B | -3.53B | 6.10B |
| 2012 | 7.07B | -5.94B | -8.88B |
| 2016 | 10.92B | -3.26B | -8.22B |
| 2018 | 13.03B | -6.17B | -9.01B |
| 2020 | 15.42B | -3.27B | -10.50B |
| 2021 | 17.84B | -7.39B | -17.09B |
| 2023 | 6.60B | -5.44B | -1.56B |
| 2024 | 9.71B | -6.07B | -4.32B |
JUBLPHARMA.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 10.13B | 9.83B | 12.30B | 10.05B | 4.56B | 3.91B | 10.41B | 5.03B | 3.81B |
Operating activities | |||||||||
Net income | 771M | 277.8M | 12.12B | 12.10B | 8.59B | 5.84B | 145.61M | 2.40B | 5.17B |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 3.81B | 5.54B | 4.51B | 4.61B | 4.15B | 3.45B | 2.61B | 1.92B | 1.24B |
Stock-based compensation expense | 85M | 37M | 2.46M | 0 | 0 | 5.32M | 0 | 0 | 0 |
| Deferred income tax benefit | 85M | 37M | 2.46M | 0 | 0 | 5.32M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 494M | 385.53M | -1.12B | 2.19B | -1.40B | -1.02B | 0 | 0 | 0 |
Inventories | 908M | -646.8M | 1.34B | -3.74B | -1.34B | 509.43M | -2.82B | -1.32B | -1.10B |
Accounts payable | 232M | 2.10B | 2.28B | -251.16M | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 9.71B | 6.60B | 17.84B | 15.42B | 13.03B | 10.92B | 7.07B | 3.88B | 7.09B |
Investing activities | |||||||||
Purchases Of Investments | -80M | -126.5M | -2.02B | -36.39M | -195.72M | -45.05M | -10.25M | 0 | 0 |
Investments In Property Plant And Equipment | -8.97B | -8.14B | -5.27B | -5.74B | -4.89B | -3.55B | -6.14B | -5.81B | -3.07B |
Acquisitions Net | 0 | 374.4M | 131.94M | 310.65M | -1.30B | 3.55B | -41.64M | 0 | -520K |
Cash generated by investing activities | -6.07B | -5.44B | -7.39B | -3.27B | -6.17B | -3.26B | -5.94B | -3.53B | -2.79B |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | -100.61M | 2.62M | 10.23M | 196.55M | 0 | 0 | 3.80B |
Payments for dividends | -798M | -800.61M | -14.75M | -1.52B | -560.3M | -569.27M | -368.08M | -369.12M | -257.53M |
Repurchases of common stock | -274M | -40M | -100.61M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -204M | 2.31B | -19.49B | -4.98B | -6.27B | -6.41B | -6.09B | -13.13B | -4.94B |
Cash used in financing activities | -4.32B | -1.56B | -17.09B | -10.50B | -9.01B | -8.22B | -8.88B | 6.10B | -2.98B |
Net Change In Cash | -575M | 301M | -7.28B | 2.25B | -2.12B | -524.66M | -7.78B | 5.42B | 1.23B |
Cash at end of period | 9.56B | 10.13B | 5.01B | 12.30B | 2.44B | 3.39B | 2.63B | 10.45B | 5.05B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |